Parkside Financial Bank & Trust Standard Biotools Inc. Transaction History
Parkside Financial Bank & Trust
- $772 Million
- Q1 2025
A detailed history of Parkside Financial Bank & Trust transactions in Standard Biotools Inc. stock. As of the latest transaction made, Parkside Financial Bank & Trust holds 200 shares of LAB stock, worth $238. This represents 0.0% of its overall portfolio holdings.
Number of Shares
200Holding current value
$238% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding LAB
# of Institutions
151Shares Held
280MCall Options Held
6KPut Options Held
36.6K-
Casdin Capital, LLC New York, NY76.1MShares$90.5 Million9.61% of portfolio
-
Viking Global Investors LP58.7MShares$69.8 Million0.21% of portfolio
-
Black Rock Inc. New York, NY21.8MShares$25.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.2MShares$20.5 Million0.0% of portfolio
-
Morgan Stanley New York, NY10.7MShares$12.7 Million0.0% of portfolio
About STANDARD BIOTOOLS INC.
- Ticker LAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 78,654,800
- Market Cap $93.6M
- Description
- Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...